These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34121919)

  • 1. Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye.
    Wang J; Li B; Huang D; Norat P; Grannonico M; Cooper RC; Gui Q; Chow WN; Liu X; Yang H
    Chem Eng J; 2021 Dec; 425():. PubMed ID: 34121919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs.
    Holden CA; Tyagi P; Thakur A; Kadam R; Jadhav G; Kompella UB; Yang H
    Nanomedicine; 2012 Jul; 8(5):776-83. PubMed ID: 21930109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mildly Cross-Linked Dendrimer Hydrogel Prepared via Aza-Michael Addition Reaction for Topical Brimonidine Delivery.
    Wang J; Williamson GS; Lancina Iii MG; Yang H
    J Biomed Nanotechnol; 2017 Dec; 13(9):1089-1096. PubMed ID: 29479294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.
    Yang H; Tyagi P; Kadam RS; Holden CA; Kompella UB
    ACS Nano; 2012 Sep; 6(9):7595-606. PubMed ID: 22876910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery.
    Lancina MG; Singh S; Kompella UB; Husain S; Yang H
    ACS Biomater Sci Eng; 2017 Aug; 3(8):1861-1868. PubMed ID: 29152562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation.
    Taka E; Karavasili C; Bouropoulos N; Moschakis T; Andreadis DDD; Zacharis CKK; Fatouros DGG
    Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32575910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamidoamine Dendrimer Microgels: Hierarchical Arrangement of Dendrimers into Micrometer Domains with Expanded Structural Features for Programmable Drug Delivery and Release.
    Wang J; Cooper RC; He H; Li B; Yang H
    Macromolecules; 2018 Aug; 51(15):6111-6118. PubMed ID: 30705466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System.
    Prabhu P; Nitish KR; Koland M; Harish N; Vijayanarayan K; Dhondge G; Charyulu R
    J Young Pharm; 2010 Oct; 2(4):356-61. PubMed ID: 21264093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid dendrimer hydrogel/poly(lactic-co-glycolic acid) nanoparticle platform: an advanced vehicle for topical delivery of antiglaucoma drugs and a likely solution to improving compliance and adherence in glaucoma management.
    Yang H; Leffler CT
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):166-72. PubMed ID: 23249385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.
    Samy KE; Cao Y; Kim J; Konichi da Silva NR; Phone A; Bloomer MM; Bhisitkul RB; Desai TA
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):124-131. PubMed ID: 30615539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.
    Lancina MG; Wang J; Williamson GS; Yang H
    Mol Pharm; 2018 Jul; 15(7):2883-2889. PubMed ID: 29767982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Polymers on Drug Release Kinetics in Nanoemulsion
    Vijaya Rani KR; Rajan S; Bhupathyraaj M; Priya RK; Halligudi N; Al-Ghazali MA; Sridhar SB; Shareef J; Thomas S; Desai SM; Pol PD
    Polymers (Basel); 2022 Jan; 14(3):. PubMed ID: 35160417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
    Shrivastava N; Khan S; Baboota S; Ali J
    Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma.
    Dubey A; Prabhu P
    Int J Pharm Investig; 2014 Jul; 4(3):112-8. PubMed ID: 25126524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.
    Fuwa M; Shimazaki A; Odani-Kawabata N; Kirihara T; Taniguchi T; Iwamura R; Yoneda K; Kato M; Morishima K; Shams NK
    J Ocul Pharmacol Ther; 2021 May; 37(4):223-229. PubMed ID: 33600237
    [No Abstract]   [Full Text] [Related]  

  • 17. Metal-organic frameworks, NH
    Kim SN; Park CG; Huh BK; Lee SH; Min CH; Lee YY; Kim YK; Park KH; Choy YB
    Acta Biomater; 2018 Oct; 79():344-353. PubMed ID: 30134206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
    Sharma PK; Chauhan MK
    Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-loaded chitosan film prepared via facile solution casting and air-drying of plain water-based chitosan solution for ocular drug delivery.
    Li B; Wang J; Gui Q; Yang H
    Bioact Mater; 2020 Sep; 5(3):577-583. PubMed ID: 32405573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate.
    Kasuya Y; Sano I; Makino S; Kawashima H
    Case Rep Ophthalmol Med; 2020; 2020():4803651. PubMed ID: 32547800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.